The US Food and Drug Administration (USFDA) has given approval to Indian pharmaceutical major Aurobindo Pharma Ltd to produce and market Telmisartan tablets for the treatment of essential or primary hypertension. The approval was granted for Telmisartan tablets USP 20 mg, 40 mg and 80 mg, as per the company.